fda glp-1 enforcement news october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Issues Warnings Against Illegal
Description
Experience safe, effective medical weight loss with proven results that last at Saltz Wellness.

Pens, vials, needles, cartridges, and alcohol wipes shown in photos are not included

Earlier use of pharmacotherapy is encouraged Medications should be considered early, especially in patients withor at high risk ofobesity-related complications

The article, publ

Philippines Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is valued at around $34.6 Mn in 2022 and is projected to reach $65.2 Mn by 2030, exhibiting a CAGR of 8.23% during the forecast period 2023-2030.

Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults
